COPENHAGEN, Denmark, September 13 /PRNewswire/ -- Bang & Olufsen Medicom, an innovative drug delivery device solutions provider for the pharmaceutical industry, has today unveiled its new disposal breath-actuated inhaler - Aspira(M). The product will be on public display for the first time at the EASD - European Association for the Study of Diabetes - conference which begins this week in Copenhagen, Denmark. Aspira(TM) is designed for use with liquid drug formulations suitable for pMDIs (pressurized metered dose inhalers). The inhaler offers a cost-effective and improved pulmonary drug delivery for treating diseases, including diabetes.
